Anticancer composition comprising antitumor agent and substance having inhibitory effects on L1CAM activity and expression

Details for Australian Patent Application No. 2009320542 (hide)

Owner Korea Research Institute of Bioscience and Biotechnology

Inventors Hong, Hyo Jeong; Min, Jeong-Ki; Yoon, Hyunho; Lee, Jung Whoi

Agent FB Rice

Pub. Number AU-A-2009320542

PCT Pub. Number WO2010/062143

Priority 10-2008-0118921 27.11.08 KR

Filing date 27 November 2009

Wipo publication date 3 June 2010

International Classifications

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/062143 Priority application(s): WO2010/062143

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009320629-Method, apparatus, and system for enabling purchaser to direct payment approval, settlement, and membership subscription using mobile communication terminal

2009320519-Method of determining an access mode of cell in a wireless communication system